Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
ED ›
EDROMEK
Trademark search for:
EDROMEK
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-09-23 — Application filed
2014-09-26 — Application filed
2014-10-01 — Application filed
2015-01-10 — Approved for pub - principal register
2015-01-10 — Assigned to examiner
2015-01-28 — Notification of notice of publication e-mailed
2015-02-17 — Published for opposition
2015-02-17 — Official gazette publication confirmation e-mailed
2015-04-14 — Noa e-mailed - sou required from applicant
2015-06-23 — Teas change of correspondence received
2015-09-08 — Sou teas extension received
2015-09-08 — Sou extension 1 filed
2015-09-08 — Sou extension 1 granted
2015-09-10 — Notice of approval of extension request e-mailed
2016-03-03 — Sou teas extension received
2016-03-03 — Sou extension 2 filed
2016-04-05 — Case assigned to intent to use paralegal
2016-04-09 — Sou extension 2 granted
2016-04-12 — Notice of approval of extension request e-mailed
2016-09-12 — Sou teas extension received
2016-09-12 — Sou extension 3 filed
2016-10-11 — Sou extension 3 granted
2016-10-12 — Notice of approval of extension request e-mailed
2017-04-12 — Sou teas extension received
2017-04-12 — Sou extension 4 granted
2017-04-12 — Sou extension 4 filed
2017-04-15 — Notice of approval of extension request e-mailed
2017-09-27 — Sou teas extension received
2017-09-27 — Sou extension 5 filed
2017-10-04 — Case assigned to intent to use paralegal
2017-10-04 — Sou extension 5 granted
2017-10-05 — Notice of approval of extension request e-mailed
2018-05-21 — Application abandoned
2018-05-21 — Application abandoned
2018-05-21 — Final status recorded
Owner Information
Glaxo Group Limited
Glaxo Group Limited
Correspondent
CHRISTOPHER M. HANES GlaxoSmithKline
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
